Skip to main content
Top
Published in: Pathology & Oncology Research 2/2020

01-04-2020 | Metastasis | Original Article

MicroRNA-182-5p Modulates Oral Squamous Cell Carcinoma Migration and Invasion Via Targeting MTSS1 Gene

Authors: Yan Guo, Xue Qiao, Li Zhu, Rongbo Song

Published in: Pathology & Oncology Research | Issue 2/2020

Login to get access

Abstract

Oral squamous cell carcinoma (OSCC) characterized with invasive growth, local metastasis and later stage diagnosis was a common malignancy in head and neck region. The aim of this study was to explore the relationship between miR-182-5p and OSCC, which will contribute to find potential biomarker for OSCC metastasis. MiR-182-5p expression level was detected by the quantitative real-time PCR (qRT-PCR). Cell migration and invasion ability were examined by scratch and transwell assay. Loss-of function together with luciferase reporter assay were used to verify the miR-182-5p modulated OSCC cells migration and metastasis was mediated by MTSS1. The expression of MTSS1 protein was examined by western blotting. MiR-182-5p up-regulated in OSCC, was involved in the migration and invasion of OSCC and the increased miR-182-5p expression was correlated with lower OSCC differentiation grade, higher T and N stage. Bioinformatics analysis predicted MTSS1 gene was a potential target of miR-182-5p. Following co-transfection, qRT-PCR, luciferase activities assay and western blotting confirmed that MTSS1 gene was a direct target of miR-182-5p and silence of MTSS1 could reverse the effects of miR-182-5p on OSCC migration and invasion. MiR-182-5p was up-regulated in OSCC and the ability of miR-182-5p to promote MTSS1 repression may precipitate in the OSCC through bypassing cell migration and invasion control.
Literature
1.
go back to reference Krishna Rao SV, Mejia G, Roberts-Thomson K, Logan R (2013) Epidemiology of oral cancer in Asia in the past decade--an update (2000-2012). Asian Pac J Cancer Prev 14:5567–5577CrossRef Krishna Rao SV, Mejia G, Roberts-Thomson K, Logan R (2013) Epidemiology of oral cancer in Asia in the past decade--an update (2000-2012). Asian Pac J Cancer Prev 14:5567–5577CrossRef
2.
go back to reference de Morais EF, Mafra RP, Gonzaga AK,de Souza DL, Pinto LP, da Silveira ÉJ (2016) Prognostic Factors of Oral Squamous Cell Carcinoma in Young Patients: A Systematic Review. J Oral Maxillofac Surg, pii: S0278–2391(16): 31286–31281 de Morais EF, Mafra RP, Gonzaga AK,de Souza DL, Pinto LP, da Silveira ÉJ (2016) Prognostic Factors of Oral Squamous Cell Carcinoma in Young Patients: A Systematic Review. J Oral Maxillofac Surg, pii: S0278–2391(16): 31286–31281
3.
go back to reference Kessler P, Grabenbauer G, Leher A, Bloch-Birkholz A, Vairaktaris E, Neukam FW (2008) Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma Long-term survival in a prospective, non-randomized study. Br J Oral Maxillofac Surg 46(1):1–5CrossRef Kessler P, Grabenbauer G, Leher A, Bloch-Birkholz A, Vairaktaris E, Neukam FW (2008) Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma Long-term survival in a prospective, non-randomized study. Br J Oral Maxillofac Surg 46(1):1–5CrossRef
4.
go back to reference Leemans CR, Braakhuis BJ, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11:9–22CrossRef Leemans CR, Braakhuis BJ, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11:9–22CrossRef
5.
go back to reference Huang S, Tan X, Huang Z, Chen Z, Lin P, Fu SW (2018) microRNA biomarkers in colorectal cancer liver metastasis. J Cancer 9(21):3867–3873CrossRef Huang S, Tan X, Huang Z, Chen Z, Lin P, Fu SW (2018) microRNA biomarkers in colorectal cancer liver metastasis. J Cancer 9(21):3867–3873CrossRef
6.
go back to reference Shen J, Zhou W, Bi N, Song YM, Zhang FQ, Zhan QM, Wang LH (2018) MicroRNA-886-3P functions as a tumor suppressor in small cell lung cancer. Cancer Biol Ther 19(12):1185–1192CrossRef Shen J, Zhou W, Bi N, Song YM, Zhang FQ, Zhan QM, Wang LH (2018) MicroRNA-886-3P functions as a tumor suppressor in small cell lung cancer. Cancer Biol Ther 19(12):1185–1192CrossRef
7.
go back to reference Shang C, Guo Y, Hong Y, Xue YX (2016) Long non-coding RNA TUSC7, a target of miR-23b, plays tumor-suppressing roles in human gliomas. Front Cell Neurosci 10:235CrossRef Shang C, Guo Y, Hong Y, Xue YX (2016) Long non-coding RNA TUSC7, a target of miR-23b, plays tumor-suppressing roles in human gliomas. Front Cell Neurosci 10:235CrossRef
8.
go back to reference Kong P, Chen L, Yu M, Tao J, Liu J, Wang Y, Pan H, Zhou W, Wang S (2018) miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer. Cell Death Dis 9(11):1059CrossRef Kong P, Chen L, Yu M, Tao J, Liu J, Wang Y, Pan H, Zhou W, Wang S (2018) miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer. Cell Death Dis 9(11):1059CrossRef
9.
go back to reference Zhao D, Zhang Y, Song L (2018) MiR-16-1 targeted silences far upstream element binding protein 1 to advance the Chemosensitivity to Adriamycin in gastric Cancer. Pathol Oncol Res 24(3):483–488CrossRef Zhao D, Zhang Y, Song L (2018) MiR-16-1 targeted silences far upstream element binding protein 1 to advance the Chemosensitivity to Adriamycin in gastric Cancer. Pathol Oncol Res 24(3):483–488CrossRef
10.
go back to reference Shang C, Tang W, Pan C, Hu XH, Hong Y (2018) Long non-coding RNA TUSC7 inhibits temozolomide resistance by targeting miR-10a in glioblastoma. Cancer Chemother Pharmacol 81(4):671–678CrossRef Shang C, Tang W, Pan C, Hu XH, Hong Y (2018) Long non-coding RNA TUSC7 inhibits temozolomide resistance by targeting miR-10a in glioblastoma. Cancer Chemother Pharmacol 81(4):671–678CrossRef
11.
go back to reference Sharifi M, Moridnia A (2017) Apoptosis-inducing and antiproliferative effect by inhibition of miR-182-5p through the regulation of CASP9 expression in human breast cancer. Cancer Gene Ther 24(2):75–82CrossRef Sharifi M, Moridnia A (2017) Apoptosis-inducing and antiproliferative effect by inhibition of miR-182-5p through the regulation of CASP9 expression in human breast cancer. Cancer Gene Ther 24(2):75–82CrossRef
12.
go back to reference Li Y, Chen S, Shan Z, Bi L, Yu S, Li Y, Xu S (2017) miR-182-5p improves the viability, mitosis, migration, and invasion ability of human gastric cancer cells by down-regulating RAB27A. Biosci Rep 37(3):pii: BSR20170136CrossRef Li Y, Chen S, Shan Z, Bi L, Yu S, Li Y, Xu S (2017) miR-182-5p improves the viability, mitosis, migration, and invasion ability of human gastric cancer cells by down-regulating RAB27A. Biosci Rep 37(3):pii: BSR20170136CrossRef
13.
go back to reference Hirata H, Ueno K, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL, Hinoda Y, Dahiya R (2013) MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. PLoS One 8(1):e55502CrossRef Hirata H, Ueno K, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL, Hinoda Y, Dahiya R (2013) MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. PLoS One 8(1):e55502CrossRef
14.
go back to reference Suzuki R, Amatya VJ, Kushitani K, Kai Y, Kambara T, Takeshima Y (2018) miR-182 and miR-183 promote cell proliferation and invasion by targeting FOXO1 in mesothelioma. Front Oncol 8:446CrossRef Suzuki R, Amatya VJ, Kushitani K, Kai Y, Kambara T, Takeshima Y (2018) miR-182 and miR-183 promote cell proliferation and invasion by targeting FOXO1 in mesothelioma. Front Oncol 8:446CrossRef
15.
go back to reference Golbakhsh MR, Boddouhi B, Hatami N, Goudarzi PK, Shakeri M, Yahaghi E, Taheriazam A (2017) Down-regulation of microRNA-182 and microRNA-183 predicts progression of osteosarcoma. Arch Med Sci 13(6):1352–1356CrossRef Golbakhsh MR, Boddouhi B, Hatami N, Goudarzi PK, Shakeri M, Yahaghi E, Taheriazam A (2017) Down-regulation of microRNA-182 and microRNA-183 predicts progression of osteosarcoma. Arch Med Sci 13(6):1352–1356CrossRef
16.
go back to reference Xu X, Wu J, Li S, Hu Z, Xu X, Zhu Y, Liang Z, Wang X, Lin Y, Mao Y, Chen H, Luo J, Liu B, Zheng X, Xie L (2014) Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway. Mol Cancer 13:109CrossRef Xu X, Wu J, Li S, Hu Z, Xu X, Zhu Y, Liang Z, Wang X, Lin Y, Mao Y, Chen H, Luo J, Liu B, Zheng X, Xie L (2014) Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway. Mol Cancer 13:109CrossRef
17.
go back to reference Guo Y, Ren MS, Shang C, Zhu L, Zhong M (2015) MTSS1 gene regulated by miR-96 inhibits cell proliferation and metastasis in tongue squamous cellular carcinoma Tca8113 cell line. Int J Clin Exp Med 8(9):15441–15449PubMedPubMedCentral Guo Y, Ren MS, Shang C, Zhu L, Zhong M (2015) MTSS1 gene regulated by miR-96 inhibits cell proliferation and metastasis in tongue squamous cellular carcinoma Tca8113 cell line. Int J Clin Exp Med 8(9):15441–15449PubMedPubMedCentral
18.
go back to reference Marshall J (2011) Transwell(®) invasion assays. Methods Mol Biol 769:97–110CrossRef Marshall J (2011) Transwell(®) invasion assays. Methods Mol Biol 769:97–110CrossRef
19.
go back to reference Wang J, Li J, Shen J, Wang C, Yang L, Zhang X (2012) MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma. BMC Cancer 12:227CrossRef Wang J, Li J, Shen J, Wang C, Yang L, Zhang X (2012) MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma. BMC Cancer 12:227CrossRef
20.
go back to reference Lv Q, Hu JX, Li YJ, Xie N, Song DD, Zhao W, Yan YF, Li BS, Wang PY, Xie SY (2017) MiR-320a effectively suppresses lung adenocarcinoma cell proliferation and metastasis by regulating STAT3 signals. Cancer Biol Ther 18(3):142–151CrossRef Lv Q, Hu JX, Li YJ, Xie N, Song DD, Zhao W, Yan YF, Li BS, Wang PY, Xie SY (2017) MiR-320a effectively suppresses lung adenocarcinoma cell proliferation and metastasis by regulating STAT3 signals. Cancer Biol Ther 18(3):142–151CrossRef
21.
go back to reference Rajabpour A, Afgar A, Mahmoodzadeh H, Radfar JE, Rajaei F, Teimoori-Toolabi L (2017) MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells. Cancer Chemother Pharmacol 80(4):765–775CrossRef Rajabpour A, Afgar A, Mahmoodzadeh H, Radfar JE, Rajaei F, Teimoori-Toolabi L (2017) MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells. Cancer Chemother Pharmacol 80(4):765–775CrossRef
22.
go back to reference Wang J, Chen T, Shan G (2017) miR-148b regulates proliferation and differentiation of neural stem cells via Wnt/β-catenin signaling in rat ischemic stroke model. Front Cell Neurosci 11:329CrossRef Wang J, Chen T, Shan G (2017) miR-148b regulates proliferation and differentiation of neural stem cells via Wnt/β-catenin signaling in rat ischemic stroke model. Front Cell Neurosci 11:329CrossRef
23.
go back to reference Xi Z, Wang P, Xue Y, Shang C, Liu X, Ma J, Li Z, Li Z, Bao M, Liu Y (2017) Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating quaking gene isoform 6. Oncotarget. 8(15):24949–24963CrossRef Xi Z, Wang P, Xue Y, Shang C, Liu X, Ma J, Li Z, Li Z, Bao M, Liu Y (2017) Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating quaking gene isoform 6. Oncotarget. 8(15):24949–24963CrossRef
24.
go back to reference Tsuchiyama K, Ito H, Taga M, Naganuma S, Oshinoya Y, Nagano K, Yokoyama O, Itoh H (2013) Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer. Prostate. 73(8):827–834CrossRef Tsuchiyama K, Ito H, Taga M, Naganuma S, Oshinoya Y, Nagano K, Yokoyama O, Itoh H (2013) Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer. Prostate. 73(8):827–834CrossRef
25.
go back to reference Xue J, Zhou A, Wu Y, Morris SA, Lin K, Amin S, Verhaak R, Fuller G, Xie K, Heimberger AB, Huang S (2016) miR-182-5p induced by STAT3 activation promotes glioma tumorigenesis. Cancer Res 76(14):4293–4304CrossRef Xue J, Zhou A, Wu Y, Morris SA, Lin K, Amin S, Verhaak R, Fuller G, Xie K, Heimberger AB, Huang S (2016) miR-182-5p induced by STAT3 activation promotes glioma tumorigenesis. Cancer Res 76(14):4293–4304CrossRef
26.
go back to reference Zeleniak AE, Huang W, Brinkman MK, Fishel ML, Hill R (2017) Loss of MTSS1 results in increased metastatic potential in pancreatic cancer. Oncotarget. 8(10):16473–16487CrossRef Zeleniak AE, Huang W, Brinkman MK, Fishel ML, Hill R (2017) Loss of MTSS1 results in increased metastatic potential in pancreatic cancer. Oncotarget. 8(10):16473–16487CrossRef
27.
go back to reference Ling DJ, Chen ZS, Liao QD, Feng JX, Zhang XY, Yin TY (2016) Differential effects of MTSS1 on invasion and proliferation in subtypes of non-small cell lung cancer cells. Exp Ther Med 12(2):1225–1231CrossRef Ling DJ, Chen ZS, Liao QD, Feng JX, Zhang XY, Yin TY (2016) Differential effects of MTSS1 on invasion and proliferation in subtypes of non-small cell lung cancer cells. Exp Ther Med 12(2):1225–1231CrossRef
28.
go back to reference Shi W, Hasimu G, Wang Y, Li N, Chen M, Zhang H (2015) MTSS1 is an independent prognostic biomarker for survival in intrahepatic cholangiocarcinoma patients. Am J Transl Res 7(10):1974–1983PubMedPubMedCentral Shi W, Hasimu G, Wang Y, Li N, Chen M, Zhang H (2015) MTSS1 is an independent prognostic biomarker for survival in intrahepatic cholangiocarcinoma patients. Am J Transl Res 7(10):1974–1983PubMedPubMedCentral
Metadata
Title
MicroRNA-182-5p Modulates Oral Squamous Cell Carcinoma Migration and Invasion Via Targeting MTSS1 Gene
Authors
Yan Guo
Xue Qiao
Li Zhu
Rongbo Song
Publication date
01-04-2020
Publisher
Springer Netherlands
Keyword
Metastasis
Published in
Pathology & Oncology Research / Issue 2/2020
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-019-00647-8

Other articles of this Issue 2/2020

Pathology & Oncology Research 2/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine